Generation Bio Co.

BiotechnologySeries CCambridge, USgenerationbio.com

Latest round

Series C

Last raised

Jan 2020

Total raised

$237M

Investors

10

About Generation Bio Co.

Generation Bio Co.Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, US. The company focuses on developing therapeutics that utilize small interfering RNA to address autoimmune diseases. The firm was co-founded by Andy Scharenberg, Mark A, and Phillip Samayoa, with Geoffrey McDonough serving as CEO.Generation Bio specializes in developing innovative therapeutics for T cell-driven autoimmune diseases, primarily leveraging their proprietary cell-targeted lipid nanoparticles (ctLNP) technology. This technology allows for selective modulation of T cell function using small interfering RNA (siRNA), aimed at reducing autoreactive T cells responsible for conditions like multiple sclerosis and rheumatoid arthritis.00 mn from their January 2021 PRIVATE PLACEMENT to enhance their drug development pipeline. The firm aims to launch new products targeting T cell-driven autoimmune diseases and expand their reach into North American and European markets, aligning with their strategic focus on advancing ctLNP technology for better treatment options. Recent capital will support these initiatives as they continue to grow their innovative therapeutics portfolio.

Who invested in Generation Bio Co.

10 investors across 3 rounds

See all investors in Generation Bio Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 9, 2020

    Amount

    $111M

    Investors

    Locked

  2. Series B

    Feb 27, 2018

    Amount

    $100M

    Investors

    Locked

  3. Series A

    Jan 4, 2018

    Amount

    $25M

    Investors

    Locked

Questions about Generation Bio Co.

Who invested in Generation Bio Co.?

Generation Bio Co. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Generation Bio Co. raised?

Generation Bio Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Generation Bio Co. last raise money?

Generation Bio Co.'s most recent round on record is a Series C, in Jan 2020.

What does Generation Bio Co. do?

Generation Bio Co. is a biotechnology company.

Where is Generation Bio Co. headquartered?

Generation Bio Co. is headquartered in Cambridge, US.

Which VCs invest in companies like Generation Bio Co.?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Generation Bio Co.'s stage. Their profiles are linked below.

Raising like Generation Bio Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.